XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.18

-0.4%

12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (7893)	12/1/1998 5:55:00 PM
From: aknahow	Read Replies (2) of 17367

Bluegreen, I am voting YES. Why don't large pharmas do it? This is clearly explained. Once the fair value of the assets of a company are high, this type of action becomes almost impossible because of the one time tax consequences. While I don't speak for Amgen, one can surmise, (correctly or incorrectly), that they are doing all they can, as evidenced by their 3 Bermuda, affiliates to at least get some of the benefits. Advise everyone who owns shares to read the prospectus. Appreciate XOMA's management for thinking beyond the box. Clearly this is one way to add value for the shareholders, IMO, but obviously this will only be true if XOMA's drugs are approved and are a commercial success.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next